Literature DB >> 16888092

AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis.

Masahiro Nakagawa1, Motoshi Ichikawa, Keiki Kumano, Susumu Goyama, Masahito Kawazu, Takashi Asai, Seishi Ogawa, Mineo Kurokawa, Shigeru Chiba.   

Abstract

The Notch1-RBP-Jkappa and the transcription factor Runx1 pathways have been independently shown to be indispensable for the establishment of definitive hematopoiesis. Importantly, expression of Runx1 is down-regulated in the para-aortic splanchnopleural (P-Sp) region of Notch1- and Rbpsuh-null mice. Here we demonstrate that Notch1 up-regulates Runx1 expression and that the defective hematopoietic potential of Notch1-null P-Sp cells is successfully rescued in the OP9 culture system by retroviral transfer of Runx1. We also show that Hes1, a known effector of Notch signaling, potentiates Runx1-mediated transactivation. Together with the recent findings in zebrafish, Runx1 is postulated to be a cardinal down-stream mediator of Notch signaling in hematopoietic development throughout vertebrates. Our findings also suggest that Notch signaling may modulate both expression and transcriptional activity of Runx1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888092     DOI: 10.1182/blood-2006-04-019570

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

1.  Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells.

Authors:  Jennifer L Gori; Jason M Butler; Yan-Yi Chan; Devikha Chandrasekaran; Michael G Poulos; Michael Ginsberg; Daniel J Nolan; Olivier Elemento; Brent L Wood; Jennifer E Adair; Shahin Rafii; Hans-Peter Kiem
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

2.  RUNX3 maintains the mesenchymal phenotype after termination of the Notch signal.

Authors:  YangXin Fu; Alex Chia Yu Chang; Michèle Fournier; Linda Chang; Kyle Niessen; Aly Karsan
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

3.  Impaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jagged1.

Authors:  Alex Robert-Moreno; Jordi Guiu; Cristina Ruiz-Herguido; M Eugenia López; Julia Inglés-Esteve; Lluis Riera; Alex Tipping; Tariq Enver; Elaine Dzierzak; Thomas Gridley; Lluis Espinosa; Anna Bigas
Journal:  EMBO J       Date:  2008-06-05       Impact factor: 11.598

4.  CBFβ and RUNX1 are required at 2 different steps during the development of hematopoietic stem cells in zebrafish.

Authors:  Erica Bresciani; Blake Carrington; Stephen Wincovitch; MaryPat Jones; Aniket V Gore; Brant M Weinstein; Raman Sood; P Paul Liu
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

5.  Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification.

Authors:  Yalin Guo; Ivan Maillard; Sankhamala Chakraborti; Ellen V Rothenberg; Nancy A Speck
Journal:  Blood       Date:  2008-04-04       Impact factor: 22.113

Review 6.  Cell cycle and developmental control of hematopoiesis by Runx1.

Authors:  Alan D Friedman
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

7.  Interferon gamma signaling positively regulates hematopoietic stem cell emergence.

Authors:  Suphansa Sawamiphak; Zacharias Kontarakis; Didier Y R Stainier
Journal:  Dev Cell       Date:  2014-12-08       Impact factor: 12.270

Review 8.  Erythro-myeloid progenitors: "definitive" hematopoiesis in the conceptus prior to the emergence of hematopoietic stem cells.

Authors:  Jenna M Frame; Kathleen E McGrath; James Palis
Journal:  Blood Cells Mol Dis       Date:  2013-10-02       Impact factor: 3.039

Review 9.  Of lineage and legacy: the development of mammalian hematopoietic stem cells.

Authors:  Elaine Dzierzak; Nancy A Speck
Journal:  Nat Immunol       Date:  2008-02       Impact factor: 25.606

Review 10.  Signalling pathways that control vertebrate haematopoietic stem cell specification.

Authors:  Wilson K Clements; David Traver
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.